The U.S. FDA has approved Merilog (insulin-aspart-szjj), Sanofi’s biosimilar to Novolog, marking a significant step toward expanding access to affordable insulin. The approval strengthens competition in the diabetes treatment market, offering a new rapid-acting insulin option for millions of patients. ...
Clinical Symposium held on “Deeper Insights in Haematology”; Erba H7100 brings hope for early and accurate diagnosis of blood disorders...
Merger combines ultra-sensitive blood and tissue protein analysis into a unified platform. ...
With symptoms mimicking common respiratory illnesses, Human Metapneumovirus (HMNPV) is placing vulnerable populations at risk and straining healthcare systems. Learn the key precautions to stay safe....
